These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 16889754

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
    Fong WF, Wan CK, Zhu GY, Chattopadhyay A, Dey S, Zhao Z, Shen XL.
    Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship.
    Slaninová I, Brezinová L, Koubíková L, Slanina J.
    Toxicol In Vitro; 2009 Sep; 23(6):1047-54. PubMed ID: 19531378
    [Abstract] [Full Text] [Related]

  • 7. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.
    Dey S, Hafkemeyer P, Pastan I, Gottesman MM.
    Biochemistry; 1999 May 18; 38(20):6630-9. PubMed ID: 10350482
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract.
    Fong WF, Wang C, Zhu GY, Leung CH, Yang MS, Cheung HY.
    Phytomedicine; 2007 Feb 18; 14(2-3):160-5. PubMed ID: 16713217
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
    Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z.
    J Biomol Screen; 2010 Mar 18; 15(3):287-96. PubMed ID: 20150589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
    Ramachandra M, Ambudkar SV, Chen D, Hrycyna CA, Dey S, Gottesman MM, Pastan I.
    Biochemistry; 1998 Apr 07; 37(14):5010-9. PubMed ID: 9538020
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q, Cui B, Silva GL, Lantvit D, Lim E, Chai H, You M, Hollingshead MG, Mayo JG, Kinghorn AD, Pezzuto JM.
    Cancer Res; 2001 May 15; 61(10):4030-7. PubMed ID: 11358822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM.
    Cancer Res; 1995 Mar 01; 55(5):1086-91. PubMed ID: 7866993
    [Abstract] [Full Text] [Related]

  • 19. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S.
    Biochemistry; 1998 Mar 17; 37(11):3594-601. PubMed ID: 9530286
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.